ALCAM and neoplasm: Several excellent imaging modalities have been developed recently for brain tumor studies, such as quantifying millions of microvessels and their distribution,22 conjugating anti‐ALCAM antibodies to microparticles of iron oxide as a contrast agent23 and single‐dose dual‐echo acquisitions protocol,24 which promoted imaging development in tumor localization and boundary outline.